Authors

Jacob Sands, MD, Dana-Farber Cancer Institute

Latest:

Novel Treatment Approaches for SCLC and Future Perspectives

A panel of expert oncologists offer closing thoughts on the future treatment landscape and unmet needs in small-cell lung cancer.

Jacqueline Barrientos, MD, Zucker School of Medicine at Hofstra/Northwell

Jacqueline C. Barrientos, MD

Latest:

Noncovalent BTK Inhibitors in CLL

Recommendations for applying information from clinical trials presented at oncology and hematology conferences in 2021 into routine clinical practice when managing patients with chronic lymphocytic leukemia.

Jacqueline C. Barrientos, MD, MS

Latest:

CAR T-Cell Therapies in CLL

Take-home messages from ASH 2021 regarding the role of CAR T-cell therapies in chronic lymphocytic leukemia.

Jacqueline Claudia Barrientos, MD

Latest:

Dr. Barrientos on Treatment Options for Patients With TP53 Mutations or 17p Deletions in CLL

Jacqueline Claudia Barrientos, MD, MS, discusses treatment options for patients with chronic lymphocytic leukemia who harbor TP53 mutations or 17p deletions.

Jacqueline D. Barrientos, MD, MS

Latest:

Dr. Barrientos on the Challenges in CLL

Jacqueline D. Barrientos, MD, MS, CLL Research and Treatment Program, Northwell Health Systems, discusses the current challenges oncologists are faced with in the field of chronic lymphocytic leukemia.

Jacqueline S. Garcia, MD

Latest:

Dr. Garcia on Future Expectations of Trials and Therapies in Myelofibrosis

Jacqueline S. Garcia, MD, discusses the future expectations of trials and therapies to improve outcomes in myelofibrosis.

Jad Hayes, MS

Latest:

Can New Oncology Payment Programs Help Stabilize Medicare?

Studies have raised doubts about the value Medicare and other payers are getting for the care they pay for, including in oncology. This has intensified the demand for new value-based care models such as the Merit-based Incentive Payment System and the Oncology Care Model.

Jae H. Park, MD

Latest:

Dr Park on the FDA Approval of Obe-Cel in Adult R/R ALL

Jae Park, MD, discusses the FDA approval of obe-cel for adult patients with relapsed or refractory acute lymphoblastic leukemia.

Jae Kim, MD

Latest:

Minimally Invasive Esophagectomy Improves Outcomes, But Remains Underutilized

Surgery remains the most effective curative treatment for esophageal cancer. Yet, many eligible patients do not undergo esophagectomy.

Jae Park, MD

Jae Park, MD, is chief of Cellular Therapy Service at Memorial Sloan Kettering Cancer Center in New York, New York.

Latest:

QOL Data With Obe-Cel in Acute Lymphoblastic Leukemia

Bijal Shah, MD, MS, and Jae Park, MD, discuss quality-of-life data for obe-cel in acute lymphoblastic leukemia.

Jae Park, MD, Memorial Sloan Kettering Cancer Center

Latest:

ASH 2021: Updates in the Chronic Lymphocytic Leukemia Treatment Landscape

Following the ASH 2021 annual meeting, expert hematologist/oncologists discuss updates in chronic lymphocytic leukemia.

Jae Y. Kim, MD

Latest:

Dr. Kim on the Safety of Immune Checkpoint Inhibition in Surgical Patients With Lung Cancer

Jae Y. Kim, MD, chief, Division of Thoracic Surgery, Department of Surgery, assistant professor, Department of Surgery, City of Hope, discusses the use of immune checkpoint inhibitors in surgical patients with lung cancer.

Jaideep Shenoi, MD

Latest:

The Art of Analogies in the Clinic

Translating medical nomenclature into language that is easily understood by patients can be difficult.

Jake Gibson

Latest:

Ars Medica: Soothing cancer patients through art therapy

Before Western medicine took root, therapies often tapped both the mind and body to promote healing.

Jake Micallef, PhD

Latest:

Dr. Micallef on NuQ Blood Tests in Prostate Cancer

Jake Micallef, PhD, chief scientific officer, VolitionRX, discusses the science of the NuQ biomarker assay as a detection tool for early-stage prostate cancer.

Jalid Sehouli, MD

Latest:

Dr. Sehouli Discusses Unmet Needs in Ovarian Cancer

Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, discusses the unmet needs for patients with ovarian cancer.

Jame Abraham, MD

Latest:

Sharing the Latest in Breast Cancer Care With Drs Rena Callahan and Jame Abraham

Jame Abraham, MD, of Cleveland Clinic, and Rena D. Callahan, MD, of UCLA, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in breast cancer presented during the 2024 San Antonio Breast Cancer Symposium.

Jame Abraham, MD, FACP

Latest:

Achieving Career Success in Academic Oncology

Academic oncologists have a critical role as opinion leaders and shape the future of cancer care by research and training future oncologists, residents, and medical students.

James A. Jorgenson, RPh, MS

Latest:

Specialty Pharmacy: Status and Future Direction

When talking about specialty pharmacy, I am reminded of the famous words of Supreme Court Justice Potter Stewart as he ruled on a 1964 obscenity case.